MINK THERAPEUTICS Trademark

Trademark Overview


On Thursday, July 29, 2021, a trademark application was filed for MINK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MINK THERAPEUTICS trademark a serial number of 90855575. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, August 1, 2025. This trademark is owned by AgenTus Therapeutics, Inc.. The MINK THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biological preparations, namely, cell therapies for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease

Pharmaceutical, medical, scientific, and biopharmaceutical research and development
mink therapeutics

General Information


Serial Number90855575
Word MarkMINK THERAPEUTICS
Filing DateThursday, July 29, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateFriday, August 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements


Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biological preparations, namely, cell therapies for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical, medical, scientific, and biopharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 28, 2022
Primary Code005
First Use Anywhere DateWednesday, December 1, 2021
First Use In Commerce DateWednesday, December 1, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 28, 2022
Primary Code042
First Use Anywhere DateWednesday, December 1, 2021
First Use In Commerce DateWednesday, December 1, 2021

Trademark Owner History


Party NameMINK THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02421

Party NameMINK THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02421

Party NameAgenTus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Wednesday, March 9, 2022ASSIGNED TO EXAMINER
Wednesday, March 9, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 17, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 9, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 17, 2022WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 27, 2023SOU EXTENSION 1 FILED
Monday, February 27, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 5, 2023SOU EXTENSION 2 FILED
Tuesday, September 5, 2023SOU EXTENSION 2 GRANTED
Thursday, September 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2024SOU EXTENSION 3 FILED
Friday, March 1, 2024SOU EXTENSION 3 GRANTED
Friday, March 1, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 6, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 6, 2024SOU EXTENSION 4 FILED
Monday, March 3, 2025SOU EXTENSION 5 FILED
Tuesday, March 4, 2025SOU TEAS EXTENSION RECEIVED
Thursday, June 26, 2025SOU EXTENSION 5 GRANTED
Friday, June 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 17, 2025USE AMENDMENT FILED
Thursday, July 17, 2025TEAS STATEMENT OF USE RECEIVED
Friday, September 6, 2024SOU EXTENSION 4 GRANTED
Tuesday, June 24, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 1, 2025STATEMENT OF USE PROCESSING COMPLETE